| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70377-012-23 | 70377-012 | HUMAN PRESCRIPTION DRUG | EVEROLIMUS | everolimus | TABLET | ORAL | 20240517 | N/A | ANDA | ANDA214182 | Biocon Pharma Inc. | EVEROLIMUS | 7.5 mg/1 | 4 BLISTER PACK in 1 CARTON (70377-012-23) / 7 TABLET in 1 BLISTER PACK |
| 70377-013-11 | 70377-013 | HUMAN PRESCRIPTION DRUG | EVEROLIMUS | everolimus | TABLET | ORAL | 20230608 | N/A | ANDA | ANDA214182 | Biocon Pharma Inc. | EVEROLIMUS | 10 mg/1 | 30 TABLET in 1 BOTTLE (70377-013-11) |
| 70377-013-22 | 70377-013 | HUMAN PRESCRIPTION DRUG | EVEROLIMUS | everolimus | TABLET | ORAL | 20211001 | N/A | ANDA | ANDA214182 | Biocon Pharma Inc. | EVEROLIMUS | 10 mg/1 | 4 BLISTER PACK in 1 CARTON (70377-013-22) / 7 TABLET in 1 BLISTER PACK |
| 70377-013-23 | 70377-013 | HUMAN PRESCRIPTION DRUG | EVEROLIMUS | everolimus | TABLET | ORAL | 20240517 | N/A | ANDA | ANDA214182 | Biocon Pharma Inc. | EVEROLIMUS | 10 mg/1 | 4 BLISTER PACK in 1 CARTON (70377-013-23) / 7 TABLET in 1 BLISTER PACK |